Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.

A. Kerbrat 1, 2 S Hamonic 3 E Leray 2 I Tron 4 Gilles Edan 2, 5, 1 J Yaouanq 2
1 VisAGeS - Vision, Action et Gestion d'informations en Santé
INSERM - Institut National de la Santé et de la Recherche Médicale : U746, Inria Rennes – Bretagne Atlantique , IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE
Résumé : Multiple sclerosis (MS) prognosis remains a challenge for both patients and physicians. Complementary to natural history studies, updated population-based data from the first event suggestive of MS, at the time of the first approved disease modifying drug (DMD), are needed. Our objective was to provide a 10-year history of MS from clinical onset at time of first approved DMDs in a population-based cohort.
Type de document :
Article dans une revue
European Journal of Neurology, Wiley, 2015, 22 (3), pp.507-e35. 〈10.1111/ene.12600〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-01103117
Contributeur : Gilles Edan <>
Soumis le : mercredi 14 janvier 2015 - 10:01:37
Dernière modification le : mercredi 16 mai 2018 - 11:23:34

Lien texte intégral

Identifiants

Citation

A. Kerbrat, S Hamonic, E Leray, I Tron, Gilles Edan, et al.. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.. European Journal of Neurology, Wiley, 2015, 22 (3), pp.507-e35. 〈10.1111/ene.12600〉. 〈inserm-01103117〉

Partager

Métriques

Consultations de la notice

258